Information  X 
Enter a valid email address

Company Name matching 'Enochian BioSciences, Inc.'

Date
Time Source
Company
Announcement
25 Jul 2022 3:15 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor
01 Jul 2022 10:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data
31 May 2022 1:00 pm GNW   Enochian BioSciences, Inc. Scientific Leaders Agree on Promise of Enochian BioSciences
25 May 2022 9:20 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company
20 Apr 2022 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience
07 Apr 2022 11:00 am GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years’ Experience at Pfizer
05 Apr 2022 11:00 am GNW   Enochian BioSciences, Inc. Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit
15 Mar 2022 11:00 am GNW   Enochian BioSciences, Inc. Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans
03 Dec 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors
18 Oct 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month
15 Oct 2021 11:00 pm GNW   Enochian BioSciences, Inc. Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity
12 Oct 2021 11:00 pm GNW   Enochian BioSciences, Inc. Fireside Chat with Enochian BioSciences’CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference
27 Sep 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection
13 Sep 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference
30 Aug 2021 12:00 pm GNW   Enochian BioSciences, Inc. Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences’ Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants
23 Aug 2021 3:18 pm GNW   Enochian BioSciences, Inc. Distinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board
20 Jul 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer
12 Jul 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
30 Jun 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity
21 Jun 2021 12:00 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
14 Jun 2021 7:53 pm GNW   Enochian BioSciences, Inc. Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
  12:00 pm GNW   Enochian Biosciences, Inc. Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure
12 May 2021 9:29 pm GNW   Enochian Biosciences, Inc. Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
07 Mar 2019 5:45 pm GNW   Enochian Biosciences, Inc. Successful Treatment of “London Patient” Underscores Clinical Potential of Enochian Biosciences’ Gene Modified Cellular Therapy for HIV
05 Dec 2018 1:30 pm GNW   Enochian Biosciences, Inc. Enochian Biosciences Announces Uplisting to Nasdaq Under Symbol “ENOB”


Company Announcements Archive »


a d v e r t i s e m e n t